✦ LIBER ✦

Clinical implications of CYP2D6 genotyping on tamoxifen treatment in breast cancer

✍ Scribed by V.O. Dezentje; J.W.R. Nortier; H.J. Guchelaar; C.J.H. van de Velde; H. Gelderblom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Implications of CYP2D6 Genotype

✍ Lim, H.-S.; Ju Lee, H.; Seok Lee, K.; Sook Lee, E.; Jang, I.-J.; Ro, J. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 162 KB

Influence of CYP2D6-genotype on tamoxife

✍ Karle, Jennifer; Bolbrinker, Juliane; Vogl, Silvia; Kreutz, Reinhold; Denkert, C 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 359 KB

Impact of CYP2D6*4 genotype on progressi

✍ Stingl, Julia Carolin; Parmar, Sumit; Huber-Wechselberger, Ariana; Kainz, Alexan 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 328 KB

Tamoxifen Metabolite Concentrations, CYP

✍ Madlensky, L; Natarajan, L; Tchu, S; Pu, M; Mortimer, J; Flatt, S W; Nikoloff, D 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB

Impact of CYP2D6 polymorphisms in tamoxi

✍ T. Ramón y Cajal; A. Altés; L. Paré; E. del Rio; C. Alonso; A. Barnadas; M. Baig 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 177 KB

Breast Cancer Treatment Outcome With Adj

✍ Stearns, V. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB